The major safety concerns
. Potential generation of replication competent lentivirus (RCL) during
the production process.
. In vivo recombination with endogenous lentiviral sequences.
. Insertional mutagenesis of proviral DNA in, or close to, active genes
which may trigger tumor initiation or promotion.